Anna Pons-Grífols

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice

Ferran Tarrés-Freixas, Benjamin Trinité, Anna Pons-Grífols et al. · Frontiers in Microbiology · 2022 · 76 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +17

An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses

Ferran Tarrés-Freixas, Carmen Aguilar‐Gurrieri, Maria Luisa Rodrı́guez de la Concepción et al. · npj Vaccines · 2023 · 34 citations · Full text

Pharmacy, Immunology, Molecular Biology +17

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity

Leire de Campos‐Mata, Benjamin Trinité, Andrea Modrego et al. · Nature Communications · 2024 · 22 citations · Full text

Pharmacy, Immunology, Infectious Diseases +16

Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization

Edwards Pradenas, Sílvia Marfil, Víctor Urrea et al. · iScience · 2023 · 17 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity

Raquel Ortiz, Ana Barajas, Anna Pons-Grífols et al. · International Journal of Molecular Sciences · 2023 · 11 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14